Case Challenge

Adjuvant Treatment in a 74-Year-Old Male With Stage III Colorectal Cancer

Source: Treatment Options in Colon and Rectal Cancers: The Role of Oral Therapy

Adjuvant Treatment in a 74-Year-Old Male With Stage III Colorectal Cancer


Faculty:

  • Edward Chu, MD

CME CREDIT INFORMATION

Release Date: 11/16/07

Expiration Date: 11/15/08


Physicians: maximum of 0.75 AMA PRA Category 1 Credit(s)™

Status: Please log in to view status


Learning Objectives

Upon completion of this activity, participants should be able to:

  • Evaluate adjuvant treatment strategies available for older patients with stage III colorectal cancer
  • Discuss management strategies for addressing toxicity associated with adjuvant chemotherapeutic agents in colorectal cancer
  • Describe the use of capecitabine in lieu of 5-fluorouracil/leucovorin in the treatment of stage III colorectal cancer and the rationale for its usage

Test your ability to make optimal treatment decisions using patient histories and diagnostic information and see the case unfold according to your choices. Compare your answers with your peers and our expert faculty’s recommendations, and then review the supporting data.
Disclaimer: The materials published on the Clinical Care Options Web site reflect the views of the reviewers or authors of the CCO material, not those of Clinical Care Options, LLC, the CME provider, or the companies providing educational grants. The materials may discuss uses and dosages for therapeutic products that have not been approved by the United States Food and Drug Administration. A qualified healthcare professional should be consulted before using any therapeutic product discussed. Readers should verify all information and data before treating patients or using any therapies described in these materials.

Jointly sponsored by Postgraduate Institute for Medicine and Clinical Care Options, LLC.

Educational grant provided by:

This program is supported by an independent educational grant from Roche.